Mangoceuticals inc MGRX.US Overview Analysis
MGRX AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
With insufficient quarterly financial data released by the company, we're unable to provide a rating.
MGRX Current Performance
0.56%
Mangoceuticals inc
1.31%
Avg of Sector
0.58%
S&P500
Top 10 High Relevance to MGRX
- DRUG Bright minds biosciences incValue 2Trend 2Swing Trading 2Whale Interest -Dividend 1See more
MGRX Profile
Mangoceuticals, Inc. is focused on developing men's and women's health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.